Business Wire

CA-VELODYNE-LIDAR,-INC.

18.8.2020 14:02:10 CEST | Business Wire | Press release

Share
Velodyne Lidar With Kaarta Cloud Can Produce Stunning 3D Maps

Velodyne Lidar, Inc. today announced Kaarta Cloud ® exclusively supports Velodyne’s lidar sensors. Kaarta’s new cloud-based application is a platform to process, store, and share 3D spaces. Paired with high quality lidar to capture the environment in 3D, the data is uploaded into Kaarta Cloud to quickly and easily process it into a point cloud for use. High quality 3D mobile mapping is now available to a broader consumer base.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200818005149/en/

Three Velodyne sensors – Ultra Puck™ , Puck™ and HDL-32E – are supported by Kaarta Cloud. After using a Velodyne sensor to scan the environment, Kaarta’s proprietary Kaarta Engine uses simultaneous localization and mapping (SLAM) algorithms to instantaneously process lidar data into a registered point cloud map. This enables users to produce accurate, measurable 3D models and vivid visual representations of complex environments, ranging from buildings and infrastructure to dangerous and hard-to-reach areas.

Mobile scanning systems are continually advancing and the possibilities for use are expansive. There is growing interest in lidar imaging for post-earthquake assessment, surveys of damaged buildings, aiding first responders in emergency situations and more. As the applications and sophistication of these tools grow, so does the size and complexity of the data collected, necessitating new ways of managing massive data sets that can be in excess of one billion points. To do so, Kaarta Cloud uses an ultra-high performance parallel-processed network to handle the processing of massive reality capture files. Kaarta Cloud workflow is designed to optimize operations, extract the maximum value from lidar scans, and facilitate data sharing and collaboration through its secure cloud storage platform.

Kaarta Cloud supports all of Kaarta’s robust mobile mapping systems which integrate Velodyne’s Puck, HDL-32E and Ultra Puck into Kaarta’s Stencil 2-16, Stencil 2-32 and Stencil Pro, respectively. Velodyne and Kaarta have strong experience in helping customers address mapping challenges in a wide variety of applications. For instance, Allvision and the City of Pittsburgh used a Velodyne-powered Kaarta solution to conduct detailed curb and parking analysis. This project provided information to help develop efficient and equitable urban mobility, enable quicker deliveries and significantly improve public parking experiences. Another example is McVeigh & Mangum Engineering , which used a Velodyne-powered Kaarta solution in a highly challenging initiative to document a North Carolina hospital with digital mapping.

Customers can now register for a 30-day free trial of the new Kaarta Cloud platform. Kaarta, as an Automated with Velodyne partner , will discuss how companies can use Velodyne’s lidar integration with Kaarta Cloud during a joint webinar on August 21 , from 10:00 to 10:45 a.m. PDT.

“Kaarta Cloud opens up access to Kaarta’s advanced SLAM-based technology to Velodyne’s lidar sensors, in addition to Kaarta systems,” said Kevin Dowling, CEO, Kaarta. “It provides a fast, flexible workflow to manage mobile mapping 3D data from field capture to finished data.”

“Kaarta Cloud is an exciting innovation for the growing ecosystem of software tools that allow Velodyne’s lidar customers and partners to produce awesome 3D digital twins,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Online SLAM processing of lidar data expands the capabilities, scope, ease of use and speed at which the user community can leverage Velodyne’s sensors. This will help unlock the tremendous potential for lidar-based innovation and mapping applications.”

Velodyne Ultra Puck, Puck and HDL-32E sensors deliver a high resolution image to measure and analyze a variety of environments. They provide high quality resolution and performance along with a full 360-degree environmental view to deliver real-time 3D data.

About Velodyne Lidar

Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

About Kaarta

Kaarta, an innovator of real-time mobile 3D reality capture, transforms the real world into its digital twin with speed, fidelity and ease. Kaarta’s patent-pending technology, rooted in advanced robotics, is a fast track from capture to answer, streamlining workflow, reducing time, lowering cost and providing a new level of understanding of spaces for humans and autonomous machines alike. Now the spectrum of stakeholders across AECO, facilities planners and managers, natural resource management professionals and mobile robotics developers can work from the same framework. Additional information is available at www.kaarta.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/velodyneLiDAR/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye